Evidence map›Paper›PMID 34529114›Full record

ArticleEuropean journal of applied physiology2021

Caffeine, genetic variation and anaerobic performance in male athletes: a randomized controlled trial.

Marc Sicova, Nanci S Guest, Pascal N Tyrrell, Ahmed El-Sohemy

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of applied physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02109783 (Genetic Modifiers of Caffeine Intake and Athletic Performance), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02109783 naunknown statusnot on this map

Genetic Modifiers of Caffeine Intake and Athletic Performance

TypeinterventionalSponsorUniversity of TorontoRan2014 to 2016Enrolled100ConditionsHealthyArmsCaffeine 2mg, Caffeine 4 mg, Caffeine 0
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Influence of the CYP1A2 c.European journal of nutrition · 2024
    Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marc SicovaTemerty Faculty of Medicine, Department of Nutritional Sciences, University of Toronto, 1 King's College Circle, Room 5326A, Toronto, ON, M5S 1A8, Canada.
Nanci S GuestTemerty Faculty of Medicine, Department of Nutritional Sciences, University of Toronto, 1 King's College Circle, Room 5326A, Toronto, ON, M5S 1A8, Canada.
Pascal N TyrrellFaculty of Arts and Science, Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
Ahmed El-SohemyTemerty Faculty of Medicine, Department of Nutritional Sciences, University of Toronto, 1 King's College Circle, Room 5326A, Toronto, ON, M5S 1A8, Canada. a.el.sohemy@utoronto.ca.ORCID http://orcid.org/0000-0002-8877-6414
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe effect of caffeine on anaerobic performance is unclear and may differ depending on an individual's genetics. The goal of this study was to determine whether caffeine influences anaerobic performance in a 30 s Wingate test, and if 14 single nucleotide polymorphisms (SNPs) in nine genes, associated with caffeine metabolism or response, modify caffeine's effects.

methodsCompetitive male athletes (N = 100; 25 ± 4 years) completed the Wingate under three conditions: 0, 2, or 4 mg of caffeine per kg of body mass (mg kg

resultsThere was no main effect of caffeine on Wingate outcomes. One significant caffeine-gene interaction was observed for CYP1A2 (rs762551, p = 0.004) on average power. However, post hoc analysis showed no difference in caffeine's effects within CYP1A2 genotypes for average power performance. No significant caffeine-gene interactions were observed for the remaining SNPs on peak power, average power and fatigue index.

conclusionCaffeine had no effect on anaerobic performance and variations in several genes did not modify any effects of caffeine.

trial registrationThis study was registered with clinicaltrials.gov (NCT02109783).

Indexed as

AthletesAnaerobiosisAthletic PerformanceCaffeineCytochrome P-450 CYP1A2Double-Blind MethodGenetic VariationGenotypeHumansMalePerformance-Enhancing SubstancesPolymorphism, Single NucleotideCaffeineCYP1A2 protein, humanCytochrome P-450 CYP1A2Performance-Enhancing SubstancesAnaerobicCaffeineExerciseGeneticsNutrigenomicsWingate

Identifiers

PMID34529114
OpenAlexW3200969539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.